A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1 -Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy.
Saved in:
| Title: | A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1 -Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy. |
|---|---|
| Authors: | Greco, Martina1 (AUTHOR), Gebbia, Vittorio2,3 (AUTHOR) vittorio.gebbia@unikore.it, Berardi, Rossana3,4 (AUTHOR), Usset, Antonella4,5 (AUTHOR), Ricciardi, Giuseppina5,6 (AUTHOR), La Verde, Nicla6,7 (AUTHOR), Sanò, Maria Vita7,8 (AUTHOR), Martorana, Federica8,9 (AUTHOR), Staropoli, Nicoletta9,10 (AUTHOR), Pernice, Gianfranco10,11 (AUTHOR), Bini, Gabriella11,12 (AUTHOR), Prestifilippo, Angela12,13 (AUTHOR), Giotta, Francesco13,14 (AUTHOR), Bilancia, Domenico14,15 (AUTHOR), Cipolla, Calogero15,16 (AUTHOR), De Luca, Martina1,16 (AUTHOR), Valerio, Maria Rosaria1 (AUTHOR) |
| Source: | Cancers. Jul2026, Vol. 18 Issue 13, p2042. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
